160 results
Page 2 of 8
8-K
EX-99.1
hrh0 lyv1j0xyam8q
5 Jan 22
Regulation FD Disclosure
8:00am
8-K
EX-1.1
yq4q17v 86
3 Sep 21
Entry into a Material Definitive Agreement
8:53am
8-K
EX-99.1
5klpb2txbro14
2 Aug 21
VBI Vaccines Announces Second Quarter 2021 Financial Results and Provides
8:00am
8-K
EX-99.1
w8y b759g1
29 Jun 21
VBI Vaccines Announces Initial Positive Phase 1 Data for its eVLP Vaccine Candidate Against COVID-19
7:35am
8-K
EX-99.1
uk9u2ee
10 Mar 21
VBI Vaccines Announces Initiation of Enrollment in Adaptive Phase 1/2 Study of Prophylactic COVID-19 Vaccine Candidate, VBI-2902
7:38am
S-3ASR
EX-1.2
mtok3dkkf6x35l
31 Jul 20
Automatic shelf registration
4:58pm
8-K
EX-99.2
h2twse 6ihil
22 Jun 20
Regulation FD Disclosure
8:46am
8-K
EX-10.1
61gig150di4ei u4
27 May 20
VBI Vaccines Secures $50 Million Debt Financing From K2 HealthVentures
5:15pm
8-K
EX-1.1
uqnx5ekbz
24 Apr 20
VBI Vaccines Announces Proposed Public Offering of Common Shares
6:16am